Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Fosamprenavir Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864945

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegvisomant Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864924

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5730369

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5720077

EMD:Ref Document

Bid Value: Ref Document

Closing Today

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5719969

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5719627

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5718497

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5716614

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

The Provision Of Specialist Substance Use Detoxification And Rehabilitation Services

Deadline: 31 Jul 2034

Great Britain

Ref. No.: 5612918

EMD:Ref Document

Bid Value: Ref Document

3004 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Octreotide Atc Code According To Who H01Cb02

Deadline: 31 May 2026

Germany

Ref. No.: 5038643

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Indonesia Strengthening National Tuberculosis Response Program

Deadline: 31 Mar 2027

Indonesia

Ref. No.: 4313019

EMD:Ref Document

Bid Value: Ref Document

325 Days Left

Contract Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Somatropin Omnitrope

Deadline: 10 Aug 2026

Germany

Ref. No.: 4269916

EMD:Ref Document

Bid Value: Ref Document

92 Days Left

Order Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Etanercept

Deadline: 10 Aug 2026

Germany

Ref. No.: 4210708

EMD:Ref Document

Bid Value: Ref Document

92 Days Left

Showing 24826 to 24840 of 24842 results

‹
1
2
...
1648
1649
1650
1651
1652
1653
1654
1655
1656
1657
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!